Le Lézard
Classified in: Environment, Covid-19 virus
Subject: Contest

Renewal Funds and InvestEco Capital Announce the 2020 Youth Impact Challenge


In response to the challenging times for youth as a result of COVID-19, Renewal Funds and InvestEco Capital are pleased to announce the launch of the 2020 Youth Impact Challenge.

The Challenge encourages youth (16 - 25 years old) across Canada to organize into diverse teams of three or more and to submit a three-page project idea, that will address a social or environmental issue.

Teams will be judged on originality, impact and implementation, as well as diversity. The top 30 teams will receive $1,000 and mentorship will be provided by business and non-profit leaders in the impact space. The winning team will receive $10,000.

Information on how to apply is available at: https://www.youthimpactchallenge.ca

For more information on the 2020 Youth Challenge please email: [email protected] or call +1(438) 929-2445.


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: